[Data show that reduced BRCA1 expression owing to promoter hypermethylation is frequent in therapy-related acute myeloid leukemia and that this could contribute to secondary leukaemogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE